News
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...
ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...
I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed yet.
1d
AZoLifeSciences on MSNReinvigorating T Cells Offers Hope for More Effective Cancer ImmunotherapyCD8⁺ T cells are the immune system's frontline warriors, charged with detecting and eliminating cancer cells. But in the ...
U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...
Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...
While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.
A better understanding of human smell is emerging as scientists interrogate its fundamental elements: the odor molecules that ...
COVID-19 variant N.B.1.8.1, or Nimbus, is more contagious than recent past variants and known to cause a particularly painful ...
A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results